Clinical trials
Withdrawn Phase 1 Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| OHSU Knight Cancer Institute | 2 |
| Baylor College of Medicine | 1 |
| Blaze Bioscience Inc. | 1 |
| Brown University | 1 |
| David Dickens | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Italian Sarcoma Group | 1 |
| M.D. Anderson Cancer Center | 1 |
| Matthew Ingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 21 |
| Osteosarcoma | 4 |
| Lymphoma | 3 |
| Melanoma | 3 |
| Brain Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Neuroblastoma | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.